Susquehanna International Group, LLP Ani Pharmaceuticals Inc Transaction History

Susquehanna International Group, LLP

$560 Billion
Q3 2024

A detailed history of Susquehanna International Group, LLP transactions in Ani Pharmaceuticals Inc stock. As of the latest transaction made, Susquehanna International Group, LLP holds 13,987 shares of ANIP stock, worth $791,384. This represents 0.0% of its overall portfolio holdings.

Number of Shares

13,987

Previous 25,331 44.78%

Holding current value

$791,384

Previous $1.61 Million 48.3%

% of portfolio

0.0%

Previous 0.0%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$54.33 - $65.72 $616,319 - $745,527	-11,344 Reduced 44.78%	13,987 $834,000
Q2 2024 Aug 15, 2024	SELL	$58.53 - $68.82 $1.47 Million - $1.73 Million	-25,190 Reduced 49.86%	25,331 $1.61 Million
Q1 2024 May 07, 2024	BUY	$54.2 - $69.69 $2.1 Million - $2.7 Million	38,725 Added 328.29%	50,521 $3.49 Million
Q4 2023 Feb 14, 2024	BUY	$48.72 - $65.43 $398,383 - $535,021	8,177 Added 225.95%	11,796 $650,000
Q3 2023 Nov 14, 2023	SELL	$50.28 - $64.61 $339,691 - $436,505	-6,756 Reduced 65.12%	3,619 $210,000
Q2 2023 Aug 11, 2023	SELL	$37.29 - $53.83 $90,913 - $131,237	-2,438 Reduced 19.03%	10,375 $558,000
Q1 2023 May 16, 2023	BUY	$37.61 - $45.72 $481,896 - $585,810	12,813 New	12,813 $508,000
Q3 2022 Nov 14, 2022	SELL	$29.83 - $38.01 $15,929 - $20,297	-534 Reduced 3.14%	16,465 $529,000
Q2 2022 Aug 15, 2022	SELL	$23.09 - $33.46 $315,709 - $457,498	-13,673 Reduced 44.58%	16,999 $504,000
Q1 2022 May 16, 2022	BUY	$26.91 - $47.15 $433,896 - $760,246	16,124 Added 110.83%	30,672 $862,000
Q3 2021 Nov 15, 2021	BUY	$26.48 - $35.99 $220,075 - $299,112	8,311 Added 133.25%	14,548 $477,000
Q2 2021 Aug 11, 2021	SELL	$31.86 - $38.6 $341,794 - $414,100	-10,728 Reduced 63.24%	6,237 $219,000
Q3 2020 Nov 16, 2020	SELL	$26.38 - $33.1 $281,843 - $353,640	-10,684 Reduced 38.64%	16,965 $479,000
Q2 2020 Aug 14, 2020	SELL	$29.93 - $50.1 $34,030 - $56,963	-1,137 Reduced 3.95%	27,649 $894,000
Q1 2020 May 15, 2020	BUY	$30.35 - $67.14 $632,706 - $1.4 Million	20,847 Added 262.59%	28,786 $1.17 Million
Q4 2019 Feb 14, 2020	SELL	$55.65 - $79.83 $1.62 Million - $2.32 Million	-29,115 Reduced 78.57%	7,939 $490,000
Q3 2019 Nov 14, 2019	BUY	$64.7 - $85.39 $1.72 Million - $2.26 Million	26,521 Added 251.79%	37,054 $2.7 Million
Q2 2019 Aug 16, 2019	BUY	$67.77 - $82.2 $297,984 - $361,433	4,397 Added 71.66%	10,533 $866,000
Q2 2019 Aug 14, 2019	BUY	$67.77 - $82.2 $12,130 - $14,713	179 Added 3.0%	6,136 $504,000
Q1 2019 May 15, 2019	SELL	$45.83 - $70.54 $43,813 - $67,436	-956 Reduced 13.83%	5,957 $420,000
Q4 2018 Feb 14, 2019	BUY	$41.17 - $56.44 $88,227 - $120,950	2,143 Added 44.93%	6,913 $311,000
Q3 2017 Nov 14, 2017	BUY	$43.46 - $52.49 $207,304 - $250,377	4,770	4,770 $250,000

Others Institutions Holding ANIP

# of Institutions

211

Shares Held

18.8M

Call Options Held

11.7K

Put Options Held

10.5K

View Full List

About ANI PHARMACEUTICALS INC

Ticker ANIP
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 17,426,000
Market Cap $986M
Description
ANI Pharmaceuticals, Inc., a biopharmaceutical company, develops, manufactures, and markets branded and generic prescription pharmaceuticals in the United States and Canada. It focuses on producing controlled substances, oncology products, hormones and steroids, injectables, and other formulations. The company manufactures oral solid dose produc...

More about ANIP

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna International Group, LLP with notifications on news.

Account

Susquehanna International Group, LLP Ani Pharmaceuticals Inc Transaction History